Skip to main content

Baclofen

A muscle relaxant used for nystagmus and some types of facial spasm.

Drug Class: muscle-relaxant

Baclofen is a muscle relaxant that works on the central nervous system. In neuro-ophthalmology, it's used to treat certain types of nystagmus, blepharospasm, and muscle spasms.

Key Takeaways

  • Muscle relaxant working in the central nervous system
  • Used for nystagmus and some spasms
  • May cause drowsiness
  • Don't stop suddenly—taper required
  • Often combined with other medications

How It Works

Baclofen activates GABA-B receptors in the spinal cord and brain, reducing muscle tone and spasms. It may also affect neural pathways involved in eye movements.

Common Uses

Dosing

  • Start low (5mg three times daily)
  • Increase gradually
  • Typical dose: 10-20mg three times daily
  • Higher doses may be needed

Side Effects

Common

  • Drowsiness
  • Dizziness
  • Weakness
  • Nausea
  • Confusion (especially in elderly)

With Sudden Discontinuation

Never stop baclofen suddenly after prolonged use. Withdrawal can cause seizures, hallucinations, and severe spasticity. Always taper under medical supervision.

Tips for Taking Baclofen

  • Start low to minimize drowsiness
  • Take with food if GI upset occurs
  • Avoid alcohol (increases sedation)
  • Don't stop suddenly—taper

Frequently Asked Questions

Will it make me sleepy?

Drowsiness is common, especially initially. It often improves as your body adjusts. Taking doses at bedtime may help.

Can I drive?

Be cautious initially—don't drive until you know how baclofen affects you. Once stable on a dose, many people can drive safely.

How do I know if it's working?

For nystagmus, you may notice improved vision stability. For spasms, reduced frequency or intensity. Effects may take weeks to assess fully.

Medically Reviewed Content

This article meets our editorial standards

Written by:
Hashemi Eye Care Medical Team
Medically reviewed by:
Board-Certified Neuro-Ophthalmologist (MD, Neuro-Ophthalmology)
Last reviewed:
January 30, 2025